An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

NCT00165880 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
62
Enrollment
INDUSTRY
Sponsor class

Stopped This study was stopped prematurely due to lack of efficacy.

Conditions

Interventions

Sponsor

Eisai Limited